7698-93-3 Usage
Description
Beta-Estradiol 17-hemisuccinate is a synthetic derivative of the naturally occurring hormone estradiol, which is a primary female sex hormone. It is characterized by the presence of a succinate group at the 17-position, which allows for the formation of noncovalent interactions with specific receptors and molecules.
Uses
Used in Biomedical Applications:
Beta-Estradiol 17-hemisuccinate is used as a targeting agent for the preparation of noncovalently surface-modified carbon dots. These carbon dots selectively target and stain estrogen receptor (ER)-rich cancer cells, which can be particularly useful in the detection and treatment of various types of cancer that are hormone receptor-positive.
Used in Cancer Research and Treatment:
Beta-Estradiol 17-hemisuccinate is used as a research tool to study the role of estrogen receptors in cancer cell growth and proliferation. By selectively targeting ER-rich cancer cells, it can help researchers better understand the mechanisms underlying hormone-dependent cancers and develop targeted therapies for these conditions.
Used in Drug Delivery Systems:
Beta-Estradiol 17-hemisuccinate can be employed in the development of drug delivery systems that specifically target ER-rich cancer cells. By incorporating this molecule into the design of drug carriers, it may be possible to improve the selectivity and efficacy of cancer treatments, reducing side effects and increasing the therapeutic potential of various anticancer agents.
Check Digit Verification of cas no
The CAS Registry Mumber 7698-93-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,6,9 and 8 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 7698-93:
(6*7)+(5*6)+(4*9)+(3*8)+(2*9)+(1*3)=153
153 % 10 = 3
So 7698-93-3 is a valid CAS Registry Number.
InChI:InChI=1/C22H28O5/c1-22-11-10-16-15-5-3-14(23)12-13(15)2-4-17(16)18(22)6-7-19(22)27-21(26)9-8-20(24)25/h3,5,12,16-19,23H,2,4,6-11H2,1H3,(H,24,25)/t16-,17-,18+,19+,22+/m1/s1
7698-93-3Relevant articles and documents
Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders
-
Page/Page column 14, (2010/02/12)
The present invention relates to compounds of the formula or pharmaceutically acceptable salts thereof useful for the prophylaxis and treatment of degenerative bone disorders and for the acceleration of bone healing.
Estradiol 17 -hemisuccinate: an improved procedure.
Yellin
, p. 554 - 555 (2007/10/13)
A simple, rapid, high-yield, and relatively inexpensive procedure for the preparation of estradiol 17beta-hemisuccinate is described. The synthesis can be done conveniently in the ordinary biological laboratory.
